Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Differential Expression Profiles and Functional Prediction of tRNA-Derived Small RNAs in Rats After Traumatic Spinal Cord Injury

Differential Expression Profiles and Functional Prediction of tRNA-Derived Small RNAs in Rats After Traumatic Spinal Cord Injury

Front. Mol. Neurosci., 2020 · DOI: 10.3389/fnmol.2019.00326 · Published: January 10, 2020

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

Spinal cord injury (SCI) is mostly caused by trauma, leading to permanent neurological impairment. The primary mechanical injury is unavoidable, necessitating a focus on secondary injury mechanisms. Transfer RNA-derived small RNAs (tsRNAs) are short, non-coding RNAs with potential regulatory functions in various diseases. Their roles in traumatic SCI were investigated using sequencing, qRT-PCR, bioinformatics, and luciferase reporter assays. The study identified an altered tsRNA expression pattern and predicted that tiRNA-Gly-GCC-001 might be involved in the MAPK and neurotrophin pathways by targeting BDNF, thus regulating the post-SCI pathophysiologic processes.

Study Duration
Not specified
Participants
12 male Sprague–Dawley rats (250–300 g)
Evidence Level
Not specified

Key Findings

  • 1
    297 differentially expressed tsRNAs were identified in rats' spinal cord 1 day after contusion. 155 tsRNAs were significantly differentially expressed: 91 up-regulated, 64 down-regulated (fold change > 1.5; P < 0.05).
  • 2
    Bioinformatics analyses identified candidate tsRNAs (tiRNA-Gly-GCC-001, tRF-Gly-GCC-012, tRF-Gly-GCC-013, and tRF-Gly-GCC-016) potentially regulating MAPK and neurotrophin signaling pathways by targeting BDNF.
  • 3
    tiRNA-Gly-GCC-001 was identified to directly target BDNF using the luciferase reporter assay, suggesting its involvement in regulating post-SCI pathophysiologic processes.

Research Summary

The study explored the relationship between tsRNAs and SCI using next-generation sequencing, bioinformatics, qRT-PCR, and luciferase reporter assay. The researchers identified dysregulated expression of tsRNAs in rats' spinal cords after SCI and predicted the potential role of candidate tsRNAs' target genes. The findings indicated that tiRNA-Gly-GCC-001 might be involved in the MAPK and neurotrophin pathways by targeting BDNF, thereby regulating pathophysiological processes after SCI.

Practical Implications

Therapeutic Target Identification

tsRNAs, specifically tiRNA-Gly-GCC-001, represent novel molecular targets for the clinical therapy of SCI.

Diagnostic Biomarkers

tsRNA expression profiles may serve as potential biomarkers for assessing the severity and progression of SCI.

Pathway Modulation Strategies

Modulating the MAPK and neurotrophin signaling pathways via tsRNA-based interventions could offer new therapeutic avenues for SCI.

Study Limitations

  • 1
    The study only examined tsRNA expression at a single time point (24 hours after SCI), limiting understanding of dynamic changes.
  • 2
    The study primarily focused on one animal model and type of SCI, thus limiting generalizability.
  • 3
    Functional validation of candidate tsRNAs was preliminary and requires further in vitro and in vivo studies.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury